SynthesisMedicine2026
Serum 25-hydroxyvitamin D levels are associated with thyroid diseases: A systematic review and meta-analysis.
Synthesis in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundVitamin D, an important immunomodulator, has been implicated in the pathogenesis of thyroid disease. Although several studies have reported lower serum vitamin D levels in patients with autoimmune thyroid diseases (AITDS) and thyroid cancer, others have yielded shown inconsistent findings, leaving the clinical significance of vitamin D status in thyroid diseases unclear. This review aimed to clarify the association between serum vitamin D levels and thyroid diseases.
methodsObservational studies, investigating the association between serum vitamin D levels and thyroid diseases, were identified through systematic searches of the PubMed, EMBASE, Web of Science, OVID, and Cochrane Library databases, with the search last updated in March 2024. Two reviewers independently screened the identified studies, extracted relevant data, and assessed study quality using the Newcastle-Ottawa Scale. Weighted mean differences (WMDs) with 95% confidence intervals (CIs) were calculated using a random-effects model. Statistical heterogeneity was assessed using the I2 statistic, and subgroup and sensitivity analyses were performed.
resultsA total of 38 studies were included in the systematic searches. Serum vitamin D levels were significantly lower in patients with thyroid diseases than in the non-thyroid disease controls (WMD -5.42 ng/mL; 95% CI, -6.61--4.67; P < .001), especially in AITDs (Graves' disease ([WMD = -4.11 ng/mL, 95% CI: -7.37--0.85], Hashimoto's thyroiditis [WMD = -7.53 ng/mL, 95% CI: -11.27--3.8], and unclassified autoimmune thyroid disease (AITD) [WMD = -2.23 ng/mL, 95% CI: -3.25--1.21]).
conclusionPatients with thyroid disease had significantly lower vitamin D levels than individuals without thyroid diseases, and a more pronounced association was observed among patients with AITDs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.